Form 4: Roivant Sciences Director Receives Stock Grant
Insider Transaction (Form 4)
Ilan Oren, a Director of Roivant Sciences Ltd., reported multiple transactions in common stock on September 16, 2026.
Summary
- Grant/award: acquired 5,054 Common Shares on September 16, 2026; holds 123,680 after (Direct).
- Grant/award: acquired 10,531 Stock Option (Right to Buy) on September 16, 2026; holds 10,531 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Ilan Oren — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-16 | Grant/award | Common Shares | 5,054 | — | — | 123,680 |
| 2026-09-16 | Grant/award | Stock Option (Right to Buy) | 10,531 | — | — | 10,531 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-16 | Grant/award (5,054 shares) |
| 2026-09-16 | Grant/award (10,531 shares) |
Keywords
insider transaction, Form 4, ROIV, Roivant Sciences Ltd., neutral, Ilan Oren
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.